报价延迟最少15分钟:2026/01/07 16:04 EST
盘后时段
|
||||
|
8.18 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.175
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.72/-1.74
|
|
企业价值
1.46B
|
| 资产负债 |
|
每股账面净值
3.51
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
10.01M
|
|
每股收益
0.15
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971). |
